318 related articles for article (PubMed ID: 6179183)
1. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
[TBL] [Abstract][Full Text] [Related]
2. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
Fischer AM; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of sodium pentosan polysulphate in man measured by a new competitive binding assay for sulphated polysaccharides--comparison with effects upon anticoagulant activity, lipolysis and platelet alpha-granule proteins.
MacGregor IR; Dawes J; Pepper DS; Prowse CV; Stocks J
Thromb Haemost; 1985 Jun; 53(3):411-4. PubMed ID: 2413564
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC
Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant activities of pentosan polysulphate (Hémoclar) due to release of hepatic triglyceride lipase (HTGL).
Barrowcliffe TW; Gray E; Merton RE; Dawes J; Jennings CA; Hubbard AR; Thomas DP
Thromb Haemost; 1986 Oct; 56(2):202-6. PubMed ID: 2433786
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the lipolytic and anticoagulative properties of heparin and pentosan polysulphate in the thoroughbred horse.
Orme CE; Harris RC
Acta Physiol Scand; 1997 Feb; 159(2):179-85. PubMed ID: 9055947
[TBL] [Abstract][Full Text] [Related]
7. Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation.
Dol F; Sié P; Dupouy D; Boneu B
Thromb Haemost; 1986 Dec; 56(3):295-8. PubMed ID: 2436330
[TBL] [Abstract][Full Text] [Related]
8. The effect of a sulfated polysaccharide on antithrombin III.
Czapek EE; Kwaan HC; Szczecinski M
J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
[TBL] [Abstract][Full Text] [Related]
9. Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man.
Ryde M; Eriksson H; Tangen O
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):435-45. PubMed ID: 6172879
[No Abstract] [Full Text] [Related]
10. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation.
Wagenvoord R; Hendrix H; Soria C; Hemker HC
Thromb Haemost; 1988 Oct; 60(2):220-5. PubMed ID: 2464199
[TBL] [Abstract][Full Text] [Related]
11. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system--a human volunteer and experimental animal study.
Marsh NA; Peyser PM; Creighton LJ; Mahmoud M; Gaffney PJ
Thromb Haemost; 1985 Dec; 54(4):833-7. PubMed ID: 2418527
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and biological activity of pentosan polysulfate after intramuscular or subcutaneous administration for ten days in human volunteers.
Sié P; Albarede JL; Robert M; Bouloux C; Lansen J; Chigot C; Correll S; Thouvenot JP; Boneu B
Thromb Haemost; 1986 Feb; 55(1):86-9. PubMed ID: 2422778
[TBL] [Abstract][Full Text] [Related]
13. Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparin.
Vinazzer H; Haas S; Stemberger A
Thromb Res; 1980 Oct; 20(1):57-68. PubMed ID: 6163222
[No Abstract] [Full Text] [Related]
14. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).
Scully MF; Kakkar VV
Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821
[TBL] [Abstract][Full Text] [Related]
15. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system. An experimental animal study.
Marsh NA; Gaffney PJ
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):255-61. PubMed ID: 2427408
[TBL] [Abstract][Full Text] [Related]
16. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
[TBL] [Abstract][Full Text] [Related]
17. Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assay.
Dawes J; Prowse CV; Pepper DS
Thromb Res; 1986 Dec; 44(5):683-93. PubMed ID: 2433788
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of the action of an acidic sulfated polysaccharide on global blood coagulation in vitro. Preliminary study in various species of mammals and in man].
Caporiccio B; Braun M; Vignaud M; Chalet M; Teste J; Codomier L; Catayée G
C R Seances Soc Biol Fil; 1983; 177(4):412-20. PubMed ID: 6202380
[TBL] [Abstract][Full Text] [Related]
19. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
Scully MF; Kakkar VV
Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
[TBL] [Abstract][Full Text] [Related]
20. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
Scully MF; Kakkar VV
Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
